IMT-1 A translational research for practical use of dendritic cell-based immunotherapy against malignant glioma

por Akasaki, Yasuharu, Takei, Jun, Yamamoto, Yohei, Tanaka, Toshihide, Kamata, Yuko, Murahashi, Mutsunori, Murayama, Yuichi
Publicado 2021

Impact of Neoadjuvant Bevacizumab on Neuroradiographic Response and Histological Findings Related to Tumor Stemness and the Hypoxic Tumor Microenvironment in Glioblastoma: Paired C...

por Takei, Jun, Fukasawa, Nei, Tanaka, Toshihide, Yamamoto, Yohei, Tamura, Ryota, Sasaki, Hikaru, Akasaki, Yasuharu, Kamata, Yuko, Murahashi, Mutsunori, Shimoda, Masayuki, Murayama, Yuichi
Publicado 2022

A phase I clinical trial of RNF43 peptide-related immune cell therapy combined with low-dose cyclophosphamide in patients with advanced solid tumors

por Hijikata, Yasuki, Okazaki, Toshihiko, Tanaka, Yoshihiro, Murahashi, Mutsunori, Yamada, Yuichi, Yamada, Kazunari, Takahashi, Atsushi, Inoue, Hiroyuki, Kishimoto, Junji, Nakanishi, Yoichi, Oda, Yoshinao, Nakamura, Yusuke, Tani, Kenzaburo
Publicado 2018

Prognostic survival biomarkers of tumor-fused dendritic cell vaccine therapy in patients with newly diagnosed glioblastoma

por Takei, Jun, Kamata, Yuko, Tanaka, Toshihide, Fukasawa, Nei, Gomisawa, Kazutaka, Satake, Mari, Mori, Ryosuke, Yamamoto, Yohei, Suzuki, Tomoya, Oda, Ayaka, Murahashi, Mutsunori, Fukuda, Takahiro, Shimoda, Masayuki, Murayama, Yuichi, Akasaki, Yasuharu
Publicado 2023